lynda

2016 Metastatic Pancreatic Cancer Market H1 Therapeutics Development Research

Press Release   •   May 05, 2016 09:45 EDT

In-detail Table of Contents of Metastatic Pancreatic Cancer Pipeline Market

Companies Involved in Therapeutics Development AbbVie Inc., Aduro BioTech, Inc., ArQule, Inc., Array BioPharma Inc., AstraZeneca Plc, Axcentua Pharmaceuticals AB, Berg LLC, Bionomics Limited, Boehringer Ingelheim GmbH, Boston Biomedical, Inc., Bristol-Myers Squibb Company, Celgene Corporation, Clovis Oncology, Inc., Cornerstone Pharmaceuticals, Inc., CTI BioPharma Corp., CytRx Corporation, Eleison Pharmaceuticals LLC, Eli Lilly and Company, Ensol Biosciences Inc., Erytech Pharma SA, F. Hoffmann-La Roche Ltd., Fountain Biopharma Inc., Gilead Sciences, Inc., GlaxoSmithKline Plc, HanAll Biopharma Co., Ltd., Immodulon Therapeutics Ltd., Incyte Corporation, MabVax Therapeutics Holdings, Inc., Merck & Co., Inc., Merrimack Pharmaceuticals, Inc., Momenta Pharmaceuticals, Inc., NanoCarrier Co., Ltd., NantKwest, Inc., Natco Pharma Limited, NewLink Genetics Corporation, Novartis AG, Oncolytics Biotech Inc., Oncovir, Inc., Oryx GmbH & Co. KG, Pfizer Inc., Pharma Mar, S.A., Pharmacyclics, Inc., Phoenix Biotechnology, Inc., Plexxikon Inc., Precision Biologics, Inc., Redx Pharma Plc, Rexahn Pharmaceuticals, Inc., Sanofi, Silence Therapeutics Plc, Targovax AS and Zeria Pharmaceutical Co., Ltd.

Get discount on this research at http://www.rnrmarketresearch.com/contacts/discount?rname=539817 .

Research provides:

  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Metastatic Pancreatic Cancer
  • Identify potential new clients or partners in the target demographic
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Metastatic Pancreatic Cancer pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

The report provides comprehensive information on the therapeutics under development for Metastatic Pancreatic Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Metastatic Pancreatic Cancer and features dormant and discontinued projects.

Complete research report at http://www.rnrmarketresearch.com/metastatic-pancreatic-cancer-pipeline-review-h1-2016-market-report.html .

List of figures:

  • Number of Products under Development for Metastatic Pancreatic Cancer, H1 2016
  • Number of Products under Development for Metastatic Pancreatic Cancer - Comparative Analysis, H1 2016
  • Number of Products under Development by Companies, H1 2016
  • Number of Products under Investigation by Universities/Institutes, H1 2016
  • Comparative Analysis by Late Stage Development, H1 2016
  • Comparative Analysis by Clinical Stage Development, H1 2016
  • Comparative Analysis by Early Stage Products, H1 2016
  • Assessment by Monotherapy Products, H1 2016
  • Number of Products by Top 10 Targets, H1 2016
  • Number of Products by Stage and Top 10 Targets, H1 2016
  • Number of Products by Top 10 Mechanism of Actions, H1 2016
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2016
  • Number of Products by Top 10 Routes of Administration, H1 2016
  • Number of Products by Stage and Top 10 Routes of Administration, H1 2016
  • Number of Products by Top 10 Molecule Types, H1 2016
  • Number of Products by Stage and Top 10 Molecule Types, H1 2016

About Us:

RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.